conference
book now
add event to diary
email this to...
contact us

Speaking Opportunities
call for papers

If you have suggestions for speakers or topics, or have ideas for the conference format, please let us know.

Presenters & panelists will be specially selected industry leaders and experts. There are a limited number of opportunities for sponsors to particpate in the conference presentations. 

 
For speaking opportunties, contact Jill Tan on 65 6322 2705 or email for a discussion
 

Speaker opportunities
 
conference details
Conference:
Day 1
18 Nov 8.30am - 5:30pm
Day 2
19 Nov 8.30am - 5:30pm
 
Pre conference Summit:
17 Nov 9am - 5.30pm
 
Post conference Masterclass:
20 Nov 9am - 5.30pm

› Add this to my calendar

or call +65 6322 2700
 
sponsorship opportunities
From the moment you confirm your involvement in a Terrapinn event, we will provide you with outstanding marketing opportunities, with a targeted campaign that will culminate in face-to-face meetings with customers and prospects.
  • Have your logo featured on the industry's most extensive marketing campaign
  • Get cost and time effective marketing exposure to reach a relevant target audience, captive under one roof
  • Learn from the other industry leaders taking this market forward
  • Showcase products and solutions to a targeted audience of industry experts
 
 
Target your market
For details contact Wendy Wong on 65 6322 2764 or send an email
 
 
 

event partners

     

 

The Concept 

India has one of the largest populations and fastest growing economies in the world. The country’s biopharmaceutical industry has grown dramatically over the past few years, with sales exceeding US$1.5 billion. As domestic demand for improved healthcare and international opportunities for biologics increase, India will continue to expand its presence on the world biopharmaceutical stage. India is expected to emerge as a strong player as its biotech industry develops a globally competitive local industry that stands on a foundation of basic research.

Be it in R&D or manufacturing, India remains a favoured investment destination. How can this growth be sustained? What is in the pipeline? What are the short and long term plans of public and private sectors to nurture and expand the growth of the industry?  How can you position yourself to take part and benefit from this biopharma boom?   

Get your questions answered at bioLOGIC India 2008 - the most dedicated platform for you to leverage on the opportunities offered by India’s booming biopharmaceutical industry!

Backed by the resounding success of biologic India in Goa, India last year, the highly anticipating 6th annual bioLOGIC India 2008 is here!

And we are promising a BIGGER and BETTER bioLOGIC India this year for you to unleash the full potential of India’s biopharmaceutical industry!

Join us at this India’s most influential biopharmaceutical event of the year!

The ONLY international platform in India where international and Indian biopharmaceutical industry leaders convene to discuss biopharmaceutical manufacturing trends, opportunities, best manufacturing  & operational practices & methodologies and where:

  • International biopharmaceutical manufacturers share their outsourcing and partnership needs, and discuss different partnership models
     
  • Indian and international biopharmaceutical production gurus gather to discuss the best manufacturing practices and operational strategies to achieve higher efficiency and profitability
     
  • Indian biotech and biopharma leaders showcase their newest biopharmaceutical innovation to international licensors and investors
     
  • Indian CMOs to showcase their manufacturing capability and capacity to global outsourcing partners

For speaking opportunities, please contact Jill Tan at jill.tan@terrapinn.com, or call +65 6322 2705.
register today
 

silver sponsor

session sponsor



confirmed speakers include
Salah U. Ahmed Executive VP, Global R&D & CSO
Barr Laboratories USA
 
 
 
Donald Gerson
COO & President Celltrion, Korea
 
 
 
 
Suresh Vunnum Scientific Director Amgen, USA
 
 
 
 
Kim Sandell
Director, Manufacturing
Pfizer, USA
 
 
 
 
Gerhard Klement CEO & President of Biopharmaceuticals, Reliance Life Sciences, India
 
 
Jayaram Chigurupati CEO
 Zenotech, India
 
 
 
 
Ashok Khar
Head of R&D, Shantha Biotechnics, India
 
 
 
 
Narender Matena Senior VP, Corporate Development, Biological E, India
 
 
 
Fatima Da Costa Director, Process Development Goodwin Biotechnology, India
 
 
 
 
networking opportunities
sharing knowledge

other related events